CA2191562A1 - Fast dissolving dosage forms - Google Patents

Fast dissolving dosage forms

Info

Publication number
CA2191562A1
CA2191562A1 CA 2191562 CA2191562A CA2191562A1 CA 2191562 A1 CA2191562 A1 CA 2191562A1 CA 2191562 CA2191562 CA 2191562 CA 2191562 A CA2191562 A CA 2191562A CA 2191562 A1 CA2191562 A1 CA 2191562A1
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
agent
group
mixtures
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2191562
Other languages
English (en)
French (fr)
Inventor
Michelle Elizabeth Brideau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2191562A1 publication Critical patent/CA2191562A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA 2191562 1994-06-03 1995-05-31 Fast dissolving dosage forms Abandoned CA2191562A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25389094A 1994-06-03 1994-06-03
US253,890 1994-06-03

Publications (1)

Publication Number Publication Date
CA2191562A1 true CA2191562A1 (en) 1995-12-14

Family

ID=22962124

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2191562 Abandoned CA2191562A1 (en) 1994-06-03 1995-05-31 Fast dissolving dosage forms

Country Status (5)

Country Link
EP (1) EP0762869A1 (de)
JP (1) JPH10501235A (de)
BR (1) BR9507909A (de)
CA (1) CA2191562A1 (de)
WO (1) WO1995033446A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000290199A (ja) * 1999-03-31 2000-10-17 Taisho Pharmaceut Co Ltd 経口用医薬組成物
SE518184C2 (sv) 2000-03-31 2002-09-03 Perstorp Flooring Ab Golvbeläggningsmaterial innefattande skivformiga golvelement vilka sammanfogas med hjälp av sammankopplingsorgan
WO2005013944A1 (en) * 2003-08-11 2005-02-17 Merck Frosst Canada Ltd. Flavored taste-masked pharmaceutical formulation made using a one-step coating process
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
JP5443768B2 (ja) * 2006-03-16 2014-03-19 ユーロセルティック ソシエテ アノニム 医薬品球状物
US9884019B2 (en) * 2008-08-05 2018-02-06 Wyeth Llc Lyophilization above collapse
MX2011008671A (es) 2009-04-01 2011-09-06 Colgate Palmolive Co Composiciones dentifricas y metodos para el tratamiento y prevencion del deterioro de las superficies dentales.
CA2775890C (en) 2009-09-30 2016-06-21 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
MX366159B (es) 2012-11-30 2019-07-01 Acura Pharmaceuticals Inc Liberacion autorregulada de ingrediente farmaceutico activo.
GB2537652A (en) 2015-04-22 2016-10-26 Cosmetic Warriors Ltd Composition
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
JP6907486B2 (ja) * 2015-09-10 2021-07-21 大正製薬株式会社 固形製剤
JP7077589B2 (ja) * 2016-11-29 2022-05-31 大正製薬株式会社 固形製剤
CN112972439A (zh) * 2019-12-16 2021-06-18 南京亿华药业有限公司 一种愈美泡腾片及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2097155T3 (es) * 1989-10-02 1997-04-01 Cima Labs Inc Forma de dosificacion efervescente y metodo de administracion.

Also Published As

Publication number Publication date
WO1995033446A1 (en) 1995-12-14
JPH10501235A (ja) 1998-02-03
BR9507909A (pt) 1997-08-12
EP0762869A1 (de) 1997-03-19

Similar Documents

Publication Publication Date Title
EP1001748B1 (de) Verfahren zur herstellung eines granulates, geeignet zur herstellung schnell-freisetzender, im mund löslicher tabletten
US4687662A (en) Therapeutic effervescent composition
US5780046A (en) Oral formulations of S(+)-ibuprofen
EP0411952B1 (de) Rotogranulate und geschmacksabdeckende Überzüge zur Herstellung pharmazeutischer Kautabletten
JP4396033B2 (ja) 口腔内速崩壊錠およびその製造法
US5196436A (en) Dextromethorphan antitussive compositions
CN100544705C (zh) 含有活性成分的质地遮蔽颗粒
US5560913A (en) Pharmaceutical compositions
CA2335566C (en) Effervescent drug delivery system for oral administration
US6027746A (en) Chewable soft gelatin-encapsulated pharmaceutical adsorbates
EP1274398B1 (de) Herstellungsverfahren für brausegranulate
US5958445A (en) Oral Formulations of S(+)-etodolac
CA2182038A1 (en) Therapeutic agents containing thyroid hormones
CA2191562A1 (en) Fast dissolving dosage forms
US5320855A (en) Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
CA2551662A1 (en) Multiparticulate formulations for oral delivery
US20030235613A1 (en) Popping oral administration form
JPH09501421A (ja) 薬物/β−シクロデキストリン複合物を酸−塩基カップルと組み合わせて含有する医薬組成物
EP0725630A1 (de) Schnellösliche arzneidosisformen enthaltend magnesium-aluminium-silikat und mehrfachwirkstoffe
CA2169371A1 (en) Hydrolyzed gelatin as a flavor enhancer in a chewable tablet
WO1994020074A1 (en) Adsorbate compositions
JPH0656677A (ja) 制酸剤組成物
CA2298487C (en) A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets
MXPA96006041A (en) Dosage form of rapida disoluc

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead